Multiorgan Metabolic Imaging Response Assessment of Abemaciclib

Clinical trial NCT03339843 · COMPLETED

Trial details

NCT number: NCT03339843
Sponsor: Jules Bordet Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Adenocarcinoma Esophagus SCC Cholangiocarcinoma Urothelial/Bladder Cancer, Nos Endometrial Cancer

Start date: 2018-12-19
Primary completion: 2021-11-12
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.